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Background: Severe neonatal jaundice with associated acute bilirubin encephalopathy occurs frequently in low- and
middle-income countries, where advanced diagnostic technology is in short supply. In an effort to facilitate the physical
diagnosis of acute bilirubin encephalopathy, we pilot-tested a modified bilirubin induced neurologic dysfunction
scoring algorithm in a group of pediatric trainees (residents) and their mentors (consultants) in a resource-constrained
setting.
Methods: Jaundiced Nigerian infants were examined by consultant and resident pediatricians. The modified bilirubin
induced neurologic dysfunction score assigned by residents was compared with the clinical diagnosis of acute bilirubin
encephalopathy by expert consultants. Demographic information was obtained. Known risk factors were also evaluated
among infants with and without acute bilirubin encephalopathy in addition to exploratory analyses. Data were analyzed
by Statistical Analysis System; statistical significance was set at p < 0.05.
Results: Three hundred and thirty three paired modified bilirubin induced neurologic dysfunction scores (333) were
analyzed and showed excellent agreement (weighted Kappa coefficient 0.7969) between residents and consultants. A
modified bilirubin induced neurologic dysfunction score greater than or equal to 3 was highly predictive of a clinical
diagnosis of acute bilirubin encephalopathy, with sensitivity of 90.7%, specificity of 97.7%, positive predictive value of
88.9%, and negative predictive value of 98.2%. Exposure to mentholated products was strongly associated with
increased risk of acute bilirubin encephalopathy among those with known glucose-6-phosphate dehydrogenase
deficiency (odds ratio = 73.94; 95% confidence interval = 5.425-infinity) as well as among those whose G6PD phenotype
was unknown (odds ratio = 25.88; 95% confidence interval = 2.845-235.4).
Conclusions: The modified bilirubin induced neurologic dysfunction score for neonatal jaundice can be assigned
reliably by both residents and experienced pediatricians in resource-limited settings as reflected in the algorithm’s
sensitivity and specificity. It may be useful for predicting the development and severity of acute bilirubin encephalopathy
in neonates.
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Worldwide, neonatal jaundice (NNJ) is one of the most
common conditions requiring in-patient treatment in the
early postnatal period [1-3]. Successful early detection and
postnatal treatment procedures before and after hospital
discharge have made the potentially lethal neurotoxic ef-
fects of severe neonatal jaundice a rare occurrence in the
industrialized world [4,5]. For instance, it is unusual to
treat neonatal jaundice beyond phototherapy except in a
few extreme cases when exchange blood transfusion
(EBT) may be required to quickly reduce the circulating
unconjugated bilirubin concentrations and prevent the
movement of free bilirubin into the brain tissues.
In resource-limited settings however, neonatal jaundice
continues to be a major cause of neonatal mortality as
well as morbidity, characterized by acute bilirubin en-
cephalopathy (ABE), and later, kernicterus in the form of
auditory neuropathy and chorioathetoid cerebral palsy,
and mortality [6]. In Nigeria where the burden of neo-
natal jaundice is exceptionally high, many infants are
born at home or church clinics, and may die before ever
seeing a physician or other health care workers [7,8].
Neonatal jaundice is often not easily appreciated by
mothers and caregivers in the home setting until it be-
comes severe enough to deeply discolor the sclera and
the skin, at which point neurological damage may have
already occurred. Additionally, a considerable number of
infants arrive at the hospital or health care facility only
after irreversible bilirubin encephalopathy has occurred
[8]. In a recently published survey, only 51.5% of com-
munity health workers in southwest Nigeria gave a cor-
rect definition of neonatal jaundice, and only 45.5%
correctly identified danger signs [9]. Even trained med-
ical professionals may miss the clinical signs and features
of ABE, especially in the early stages, so that appropriate
intervention for infants with reversible brain injury may
be delayed [10,11]. Thus there is a need for a tool that
clinicians can use to recognize the danger signs of ABE
early enough when appropriate intervention is most
likely to lead to limiting or reversing adverse neurodeve-
lopmental outcomes.
In resource-limited settings where the diagnosis of
ABE is commonly made without magnetic resonance
imaging (MRI) or auditory brainstem response (ABR)
confirmation, experienced pediatricians are adept at rec-
ognizing this constellation of signs. However, attempts
to quantify the prevalence of ABE and its severity across
communities and among physicians with different levels
of expertise were historically limited by the lack of a uni-
form diagnostic algorithm. In 1999, the bilirubin-induced
neurologic dysfunction (BIND) scoring algorithm was de-
veloped, assigning 1, 2 or 3 points to indicate mild, mod-
erate, or severe abnormalities in an infant’s mental status,
muscle tone, or cry (Additional file 1) [12]. Higher scoresindicate worsening signs of acute neurotoxicity associated
with excessive hyperbilirubinemia, providing a common
descriptive framework for clinicians and researchers to es-
timate the severity of neonatal jaundice. The simplicity of
the BIND scoring system, similar to the Apgar score,
makes it an attractive tool for clinical diagnosis of ABE in
resource limited locations that lack ready access to MRI)
and ABR testing [13]. However, the practicality and ac-
ceptance of this scoring algorithm in such settings has not
been reported. This study was therefore designed to evalu-
ate the reliability and reproducibility of a modified BIND
(BIND-M) scoring system within the scope of the routine
newborn examination in Nigeria when used by both
trainees and consultant pediatricians. Additionally, BIND-
M scores were analyzed for utility in a subset of infants




This study was approved by the Institutional Review Boards
(IRBs) at the University of Louisville USA, the University of
Minnesota USA, the Obafemi Awolowo University Teach-
ing Hospitals Complex, Nigeria, the Ladoke Akintola Uni-
versity of Technology Teaching Hospital, Nigeria and the
University of Benin Teaching Hospital, Nigeria prior to its
initiation.
Modified BIND score
With the permission of Drs. Lois Johnson and Vinod
Bhutani, the authors of the original BIND scoring algo-
rithm (Additional file 1), the investigators developed a
modified BIND scoring algorithm (BIND-M), which in-
corporates abnormality of the upward gaze, another clas-
sic sign of bilirubin encephalopathy, with additional
qualifiers (Additional file 2). The goal was to develop a
more comprehensive score which would better discrim-
inate degrees of BIND severity. In the new scoring sys-
tem, the maximum total score for BIND-M is 12. A
score of 1-4 was predicted to be indicative of mild ABE,
which is generally considered to be reversible if treated
promptly and aggressively. An intermediate score (5-6)
was predicted to be indicative of moderate ABE, which
might be reversible with urgent and prompt bilirubin re-
duction. Even higher scores (7 and above) would likely
indicate severe/very severe ABE, probably representing
irreversible brain damage in most infants.
Data collection
One of the authors (TMS) provided initial training in
the BIND-M scoring system to the consultant pediatri-
cians at the sites, who in turn trained the resident physi-
cians. The BIND-M was then incorporated into the
routine physical examination of jaundiced infants in the
Table 1 BIND-M scores: resident versus consultant
pediatricians
BIND-M score Consultants
0 1 2 3 4 5 6 7 8 9 10 11 12 Total
Residents 0 236 11 4 1 0 0 0 1 0 1 0 0 0 254
1 8 7 1 0 0 0 0 0 0 0 0 0 0 16
2 3 2 1 1 0 1 0 0 0 0 0 0 0 8
3 0 1 1 1 0 0 1 0 0 1 0 0 0 5
4 0 0 0 1 0 1 0 1 0 1 0 0 0 4
5 1 0 0 0 0 1 0 1 0 1 1 0 0 5
6 0 0 1 0 1 1 2 0 0 0 0 1 0 6
7 0 0 0 0 1 1 0 2 0 0 0 0 0 4
8 0 2 0 0 0 1 0 1 3 1 2 2 0 12
9 0 0 0 0 0 0 0 0 0 2 1 0 0 3
10 0 0 0 0 0 0 0 0 1 2 2 0 0 5
11 0 0 0 0 0 0 0 0 3 0 0 5 0 8
12 0 0 0 0 0 0 0 0 0 0 0 1 2 3
Total 248 23 8 4 2 6 3 6 7 9 6 9 2 333
Weighted Kappa = 0.7969 (95% CI: 0.7426, 0.8512).
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tricians, who independently computed a BIND-M score
for each of 333 infants. Regardless of the score, physi-
cians also were asked to determine if they believed an
infant had the signs and symptoms of ABE, based on the
total clinical picture.
The BIND-M score and clinical determination of ABE
by the consultant pediatricians were considered to be
the reference points for this study. The total BIND-M
scores, as assessed by residents, were cross-tabulated
against the total BIND-M scores as assessed by consul-
tants. Additionally, resident and consultant findings for
each major sub-score of the BIND-M (alterations in
muscle tone, mental status, cry, and gaze) were separ-
ately cross-tabulated. For each cross-tabulation, inter-
rater agreement was assessed using the weighted Kappa
statistic, with 95% confidence intervals (CI), as com-
puted using SAS PROC FREQ.
Descriptive and exploratory analyses were conducted
using additional clinical variables where available, as well
as known risk factors for neonatal jaundice (sepsis, feto-
maternal blood groups incompatibility, G6PD deficiency,
menthol exposure). Means of continuous variables were
compared between infants with and without ABE using
SAS PROC MEANS and PROC T-TEST. Statistical sig-
nificance was set at p < 0.05. Odds ratios (ORs) for di-
chotomous and categorical variables, along with their
95% confidence intervals were calculated using uncondi-
tional logistic regression (SAS PROC LOGISTIC). Dis-
cordance at the A, B, and Rh loci were evaluated
simultaneously in a single mode. Likewise, menthol ex-
posure was evaluated in the context of G6PD deficiency,
such that infants who were neither enzyme deficient nor
exposed to menthol were the “grand” referent group to
which all others were compared.
Results
Inter-rater reliability of the BIND-M score: residents versus
consultants
Inter-rater reliability of BIND-M between pediatric resi-
dents and consultant pediatricians was determined for
333 records (Table 1). The total BIND-M scores showed
excellent agreement between residents and consultants,
as confirmed by the weighted Kappa coefficient of
0.7969 (95% CI, 0.7426, 0.8512). The sub-scores for
mental status (Table 2a), muscle tone (Table 2b), and cry
(Table 2c), likewise showed a high level of agreement,
with weighted Kappa coefficients of 0.7692 (95% CI:
0.6977, 0.8407), 0.8430 (95% CI: 0.7809, 0.9051), and
0.8139 (95% CI: 0.7321, 0.8957), respectively. Only the
simple Kappa coefficient of 0.5802 (95% CI: 0.4055,
0.7549) could be computed for the gaze sub-score
(Table 2d), since it can take on only two values: zero and
three.The consultant deemed 53 (15.9%) of the 333 infants to
have ABE. Total BIND-M scores were evaluated for clin-
ical utility in diagnosing ABE (Table 3). An overall score
greater than or equal to 3 was highly predictive of a clin-
ical diagnosis of ABE, with sensitivity of 90.7%, specificity
of 97.7%, positive predictive value of 88.9%, and negative
predictive value of 98.2%. Fifty (94.3%) of the 53 infants
with ABE had scores of “2” (“moderate”) or “3” (“severe”)
on at least one subscale (mental status, muscle tone, cry,
or eye findings). However, residents had 9 false positives
versus 8 for consultants, based on this single criterion.
The most consistently detected sign was alteration in
muscle tone. Residents scored 48 of 53 (90.6%) infants
with ABE in the “moderate-to-severe” range; the consul-
tants similarly scored 84.9% of these infants. Alteration in
mental status was a less consistent finding for ABE; resi-
dents noted “moderate-to-severe” alterations in mental
status for 42 out of the 53 (79.2%) infants with ABE versus
44 (83%) noted by the consultants. Alterations in cry were
similarly noted by residents and consultants (44 and 43 of
53, respectively). Consultants recognized paralysis of up-
ward gaze in 26 (49%) of the 53 infants with encephalop-
athy, versus only 19 (35.8%) that were detected by
residents. All infants with eye findings had a diagnosis of
ABE. However, when eye finding points were subtracted
from the BIND-M score, all infants with ABE still had a
BIND score of 3 and above.
Risk factors for neonatal jaundice
A total of 198 records met criteria for additional ex-
ploratory analyses. Pediatric consultants made a clinical
Table 2 Sub-score correlations of BIND-M scores: residents versus consultants
a: Mental status sub-scores Consultants
Weighted Kappa = 0.7692 (95% CI: 0.6977, 0.8407) 0 1 2 3 Total
Residents Normal mental status. 0 246 11 3 1 261
Sleepy, Difficult to Awaken for Feeding 1 12 10 2 0 24
Very sleepy; Alternatively very irritable 2 3 1 27 1 32
Semi-Coma; Apnea; Convulsions 3 0 2 5 9 16
Total 261 24 37 11 333
b: Muscle tone sub-scores Consultants
Weighted Kappa = 0.8430 (95% CI: 0.7809, 0.9051) 0 1 2 3 Total
Residents Normal muscle tone 0 259 7 3 1 270
Persistent mild hypotonia 1 2 7 0 0 9
Moderate hypotonia; moderate hypertonia; increasing arching of neck and trunk on stimulation without
spasms of arms & legs and without trismus
2 3 3 22 4 32
Persistent retrocollis; opisthotonus; crossing or scissoring of arms or legs but without spasms of arms & legs
and without trismus
3 1 0 3 18 22
Total 265 17 28 23 333
c: Altered cry sub-scores Consultants
Weighted Kappa = 0.8139 (95% CI: 0.7321, 0.8957) 0 1 2 3 Total
Residents Normal cry 0 279 3 1 3 286
High-pitched cry 1 4 2 1 3 10
Shrill cry 2 1 0 6 0 7
Inconsolable crying, or cry weak or absent in child with previous history of high pitched or shrill cry 3 2 1 3 24 30
Total 286 6 11 30 333
d: Altered gaze sub-scores Consultants
Simple Kappa = 0.5802 (95% CI: 0.4055, 0.7549) 0 3 Total
Residents Normal Gaze 0 301 12 313
Sun-setting; paralysis of upward gaze 3 6 14 20
Total 307 26 333
Table 3 BIND-M score versus consultant diagnosis of acute bilirubin encephalopathy (ABE)
Consultant score vs.
consultant diagnosis
Final diagnosis Test performance
ABE No ABE Sensitivity % Specificity % Positive predictive
value %
Negative predictive
value %TP FN FP TN
BIND score cut off ≥0 53 0 280 0 100.0 0.0 15.9 N/A
≥1 52 1 33 247 98.1 88.2 61.2 99.6
≥2 50 3 12 268 94.3 95.7 80.6 98.9
≥3 48 5 6 274 90.7 97.9 88.9 98.2
≥4 45 8 5 275 84.9 98.2 90.0 97.2
≥5 44 9 4 276 83.0 98.6 91.7 96.8
≥6 40 13 2 278 75.5 99.3 95.2 95.5
≥7 37 16 2 278 69.8 99.3 94.6 94.9
≥8 32 21 1 279 60.4 99.6 96.7 93.0
≥9 26 27 0 280 49.6 100.0 100.0 91.5
≥10 17 36 0 280 32.1 100.0 100.0 88.6
≥11 11 42 0 280 20.8 100.0 100.0 87.0
≥12 2 51 0 280 3.8 100.0 100.0 84.6
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serum bilirubin concentrations were almost twice as
high in infants with ABE compared to those without
ABE, and peak bilirubin > 15 mg/dL was associated with
a tenfold OR for ABE (Table 4). Sixty-nine percent of in-
fants were term (≥38 weeks), with a mean estimated ges-
tational age of 37.7 (2.7) weeks, and 82.3% were born
either at a clinic or in a hospital. The mean age at the
time of BIND-M examination was 124 (74) hours; the
mean infant weight at the time of examination was 2751
(725) grams. In infants with a clinical diagnosis of ABE,
the mean postnatal age at examination was higher than
in infants without ABE but not statistically significant
(p = 0.053). Additionally, gestational age at birth, birth
weight, weight at examination and the proportions of in-
fants with ABO and Rh blood incompatibilities did not
differ significantly between the groups.
One hundred seven of the jaundiced infants were eval-
uated for sepsis. Among these, sepsis was diagnosed in
24 (26.4%) of 91 without ABE and in 12 (75.0%) of 16
with ABE (OR = 8.375; 95% CI = 2.463, 28.48). Finally,
when ABE was cross-tabulated simultaneously with
menthol exposure and G6PD deficiency (Table 4), it was
clear that menthol exposure was strongly associated with
ABE, but statistically significant only among those whose
known G6PD phenotype was unknown (OR = 25.88;Table 4 Risk factors for acute Bilirubin encephalopathy amon












Menthol G6PD Cases Co
Unexposed Normal 1 37
Unexposed Unknown 10 63
Unexposed Deficient 3 17
Unknown Normal 1 10
Unknown Unknown 1 25
Unknown Deficient 1 6
Exposed Normal 0 0
Exposed Unknown 7 10
Exposed Deficient 4 295% CI = 2.845,235.8) or definitely deficient (OR =
73.94; 95% CI = 5.425, > 999).
Discussion
Our results have shown that the physical diagnosis of
ABE can be facilitated by a modified BIND-M score.
The score showed excellent agreement between resi-
dents and consultants (weighted Kappa = 0.7969), and
appeared to be accurate in predicting infants with ABE
(sensitivity = 90.7%; positive predictive value = 88.9%).
Thus, BIND-M may be an important yet simple tool to
provide a uniform measure of the degree of ABE in clin-
ically jaundiced infants in resource limited settings. In-
fants with BIND-M scoring less than 3 were extremely
unlikely to be diagnosed with clinical ABE (specificity =
97.7%; negative predictive value = 98.2%). Although, a
score of 5 had a higher positive predictive value of
91.7%, it is associated with an unacceptable level of false
negatives (80% increase) with an 8% reduction in sensi-
tivity. While we predicted that a score of 1-4 would be
indicative of mild ABE and 5-6 would represent moderate
ABE, a threshold as low as 3 is definitely more applicable
in this population, possibly as a result of the multiple risk
factors and a high prevalence of severe NNJ. It is note-
worthy that inter-rater agreement for the upward gaze
paralysis sub-score (simple Kappa = 0.5802) was lowerg Jaundiced Nigerian neonates
ntrols Number (%) Odds ratio [95% CI]
96 (28.8%) 1.000 [Referent]
0 135 (40.5%) 7.044 [2.061,24.07]
102 (30.6%) 10.06 [2.927,34.60]
8 333 (100.0%)
.65 P < 0.001
ntrols Number (%) Odds Ratio (95% CI)
3 120 (61.2%) 1.089 (0.470,2.523)
76 (38.8%) 1.000 (REFERENT)
ntrols Number (%) Odds Ratio (95% CI)
71 (66.4%) 1.000 (REFERENT)
36 (33.6%) 8.375 (2.463, 28.48)
ntrols Number (%) Odds Ratio (95% CI)
38 (19.2%) 1.000 (REFERENT)
73 (36.9%) 5.868 (0.722,47.66)
20 (10.1%) 6.524 (0.632,67.34)
11 (5.6%) 3.697 (0.212,64.42)
26 (13.1%) 7.120 (0.936,54.18)
7 (3.5%) 6.162 (0.338,112.2)
0 (0.0%) 0.000 (incalculable)
17 (8.6%) 25.88 (2.845,235.8)
6 (3.0%) 73.94 (5.425,>999)
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0.7692), altered muscle tone (weighted Kappa = 0.8430),
and altered cry (weighted Kappa = 0.81399) sub-scores.
Exchange blood transfusion for severe NNJ entails a sig-
nificant risk for morbidity. This procedure was quite com-
mon in the present study, where 24% of the infants at four
major teaching hospitals in Nigeria had EBT. Even in the
most experienced hands, this procedure is not without sig-
nificant risk from the procedure itself as well as the risks
for infections and non-infectious complications [14,15]. If
effectively used in combination with other modalities in-
cluding intensive phototherapy, BIND-M is capable of re-
ducing the high rate of needless EBT in newborns without
ABE as well as enhancing identification of newborns with
mild to moderate ABE, considered to be reversible with ap-
propriate and early interventions.
Glucose-6-phosphate dehydrogenase deficiency is
known to be a significant risk factor for severe neonatal
jaundice and is common in Nigeria. Testing for G6PD
deficiency is not routinely available in health institutions
and was only performed in a small subset of infants in
the present study. Exposure to mentholated products is
known to be a significant risk factor for severe jaundice
and ABE in infants with G6PD deficiency [16,17], and
yet was commonly used with the neonates in our study:
1 in 6 infants overall, and 4 in 10 infants with ABE. It is
therefore imperative to continue public enlightenment
campaigns, at least in Nigeria, to educate the populace,
and pregnant women in particular, as to the danger of
using these products in the newborn period [17].
Surprisingly, neither ABO incompatibility nor Rh dis-
ease was significantly different between the two groups of
infants with and without ABE, suggesting that other fac-
tors such as dehydration, sepsis and harmful cultural prac-
tices may play a more significant role in determining the
course and severity of newborn jaundice in this area. Con-
current sepsis has been alleged to be a significant risk fac-
tor for ABE among Nigerian neonates [18]. Sepsis usually
coexists with exposure to exogenous agents that predis-
pose the G6PD deficient infants to severe NNJ and ABE.
The primary limitation in the present study is the lack
of ABR or MRI to validate the BIND-M score. However,
since neither ABR nor MRI is the standard of care in
these settings, physicians are quite familiar with the clin-
ical diagnosis of ABE. A subsequent study to validate the
BIND-M score with ABR is now ongoing in a children’s
hospital in Lagos, Nigeria. Another significant limitation
is the lack of the full medical history for these infants.
However, since this was not the focus of this study it will
be desirable for a future study.
Conclusions
The present study has shown that the use of the BIND-M
score among consultant pediatricians and their residentdoctors in Nigeria is reliable for identifying infants with the
clinical diagnosis of ABE with acceptable sensitivity and
specificity. Validation and further modification of this scor-
ing system could provide a much needed tool for use in
population studies in Nigeria and elsewhere to estimate the
actual magnitude of ABE-related morbidity and mortality.
Such data would support the work of child health advocates
to devise solutions to reduce or eliminate this preventable
morbidity which has long-term, tragic consequences for the
infants, their families and their communities.Additional files
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